"GLP-1 medications"

A new survey from the healthcare policy think tank KFF reveals that nearly 1 in 8 adults in the United States has turned to GLP-1 drugs such as Ozempic or …

A recent study from Case Western Reserve University in Cleveland, Ohio, suggests that the diabetes drug Ozempic and other semaglutide medications may significantly reduce the risk of Alzheimer’s disease in …

Recent research has shown that Wegovy and Ozempic, two popular weight-loss drugs, may reduce the risk of several obesity-related cancers.  The findings, published in the July 5 issue of JAMA …

The American Stroke Association (ASA) has released new guidelines to help lower the risk of strokes, focusing on prevention through screening and lifestyle changes.  Strokes are the fifth-leading cause of …

More U.S. adults are being diagnosed with attention-deficit/hyperactivity disorder (ADHD).  A recent Centers for Disease Control and Prevention (CDC) report indicates that approximately 15.5 million American adults have ADHD.  This …

A recent report from the FDA’s Adverse Event Reporting System (FAERS) has linked weight loss drugs like Ozempic and Wegovy to 162 deaths in the U.S. over the past six …

The House Ways and Means Committee advanced four bills on Thursday, aiming to allow Medicare to cover weight-loss drugs for certain beneficiaries.  The vote, which passed 36-4, is a crucial …